Suchergebnisse - "Curigliano, G"

PubPharm (152)

11

Trastuzumab deruxtecan (T-DXd) in HER2-low metastatic breast cancer treatment

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2023

von Tarantino, P. | Tolaney, S. | Curigliano, G.

CommentOn: Ann Oncol. 2023 Oct;34(10):948-949. - PMID 37499869

12

Leptomeningeal metastasis from solid tumours : EANO-ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

enthalten in: ESMO open | 2023

von Le Rhun, E. | Weller, M. | van den Bent, M. | +13

13

Essential cancer medicines : adding feasibility to the magnitude of clinical benefit value chain

enthalten in: ESMO open | 2023

von Roitberg, F. | Amaral, T. | Cherny, N. | +7

14

ESMO Expert Consensus Statements on the management of breast cancer during pregnancy (PrBC)

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2023

von Loibl, S. | Azim, H. | Bachelot, T. | +21

15

ESMO-Magnitude of Clinical Benefit Scale for haematological malignancies (ESMO-MCBS:H) version 1.0

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2023

von Kiesewetter, B. | Dafni, U. | de Vries, E. | +21

16

Management of patients with HER2-positive metastatic breast cancer after trastuzumab deruxtecan failure

enthalten in: ESMO open | 2023

von Antonarelli, G. | Corti, C. | Tarantino, P. | +7

17

ESMO expert consensus statements (ECS) on the definition, diagnosis, and management of HER2-low breast cancer

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2023

von Tarantino, P. | Viale, G. | Press, M. | +29

CommentIn: Ann Oncol. 2023 Oct;34(10):948-949. - PMID 37499869

18

Corrigendum to "Tucatinib versus placebo added to trastuzumab and capecitabine for patients with pretreated HER2D metastatic breast cancer with and without brain metastases (HER2CLIMB) : final overall survival analysis": [Annals of Oncology 33 (2022) 321-329

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2023

von Curigliano, G. | Mueller, V. | Borges, V. | +17

ErratumFor: Ann Oncol. 2022 Mar;33(3):321-329. - PMID 34954044

19

Patient-reported outcomes and hospitalization data in patients with HER2-positive metastatic breast cancer receiving trastuzumab deruxtecan or trastuzumab emtansine in the phase III DESTINY-Breast03 study

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2023

von Curigliano, G. | Dunton, K. | Rosenlund, M. | +5

20

Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with metastatic colorectal cancer

enthalten in: ESMO open | 2023

von Yoshino, T. | Cervantes, A. | Bando, H. | +30